At its locations around the world, Siegfried offers employees exciting career opportunities in international settings. We cultivate multidisciplinary cooperation and encourage our staff to actively shape and influence their careers. This approach, coupled with our dynamic working environment, make Siegfried an attractive employer.
Your role
- Handling of deviations, complaints and CAPA via Trackwise system whilst ensuring consistent quality approach and closure for deviations, complaints and CAPA's to avoid re-occurrence and proper root cause identification;
- Monitoring the closure and effectiveness of corrective and preventive measures taken following such investigations ensuring lessons learnt are incorporated into the system;
- Leading the preparation of Product Quality Reviews, whilst liaising with different stakeholders to ensure PQRs are prepared promptly whilst identifying areas of product improvement in liaison with the PxLT organization;
- Form an integral role of the Internal Auditing Team.
Your profile
- A first degree in Life Sciences or related field;
- Previous experience or a combination of training and experience
- Knowledge and ability to lead a root-cause analysis by using tools such as 5 why's, fish bone etc;
- Strong organisational, interpersonal and communication skills;
- Attention to detail and capable of working on own initiative and within a team.
Working at Siegfried
Siegfried's work environment is dynamic and international. With a highly professional and motivated team, the company operates in a future-oriented business field. Siegfried possesses a unique culture that leverages cultural differences to create a competitive advantage. Siegfried places highest priority on providing a flexible, diverse and discrimination-free working environment in which employees can develop personally and professionally, advance innovation and deliver superior performance. We strive to provide a work environment where employees can take on challenging jobs and associated responsibilities that best serve their personal and technical development and can benefit from the success of our company. The company regulations in respect of compensation and career development opportunities apply to all Siegfried sites. Additional conditions of employment are governed by location-specific circumstances, legislation and customs.
Who we are
In the Midst of People’s Lives – Across the Globe The Siegfried Group is one of the world’s leading Custom Development and Manufacturing Organizations (CDMOs) developing and producing active pharmaceutical ingredients (API), intermediates and finished dosage forms. As our core competence, we successfully integrate chemical and pharmaceutical capabilities into a single business model. The Siegfried name stands for highest quality, efficiency, flexibility and safety. Present in Europe, Asia and North America, we serve a broad global customer base from major international pharmaceutical companies down to small biologic-pharmaceutical organizations. For them we develop and produce product innovations on a large scale to finished products. We integrate our offer seamlessly into the customers’ value chain. Our comprehensive services range from early-stage Research & Development services such as synthesis, scale-up, formulation development, stability studies and method development all the way through to manufacturing services, ranging from preclinical R&D material for clinical trial purposes to commercial production. We are able to produce about 200 of the approximately 1500 registered drug substances used in medicine. Moreover, we produce 20 percent of global demand for caffeine. Consequently, nearly 1 billion individuals come into contact with Siegfried products.
What we do in Hal Far
Hal Far is our drug product manufacturing site for solid dosage forms. It offers innovative and generic drug products for the global market with a competitive cost structure at Swiss quality level.
Main activities
- GMP commercial manufacturing of solid oral pharmaceutical dosage forms
- Supply of tablets, film tablets, and hard capsules filled with powder or pellets, in bulk or blister packed
- cGMP high-potency suite
Features
- 1 –10 μg / m³ segregated cGMP production areas for high-potency
- 7 GMP suites: Dry & wet granulation, Tableting (up to 2 billion unit p.a.), Capsuling (up to 1 billion unit p.a.), Coating (up to 1 billion unit p.a.), Blistering (up to 100 million blisters p.a.)
Strategic importance
- CMO for innovative and generic drug products for the global market
- Competitive cost structure at Swiss quality level